Information de base

Numéro de Référence

00002295344

Organisation émettrice

University of British Columbia

Type d’appel d’offres

DDP - Demande de proposition (Formel)

Numéro d’appel d’offres

2020010130

Titre

Fluorescence-Based Capillary Electrophoresis System

Code d’identité d’origine

SCRIBE

Détails

Emplacement

Colombie Britannique

Type d’achat

Non-mentionné

Dates

Publication

2020-08-12 09h32:00 HAE

Date de fermeture

2020-08-25 17h00:00 HAE

Information du contact

Rad, Calin

604-827-5745

calin.rad@ubc.ca

Description

The University of British Columbia, Centre for Molecular Medicine and Therapeutics intends to obtain a supplier/vendor to supply, deliver and install one (1) brand new fluorescence-based capillary electrophoresis system for Sanger DNA sequencing and DNA fragment analysis by the CMMT DNA Sequencing Core Facility. This is a CFI funded project.

Afficher davantage

Dérogation All amendments to the associated notice, including amended documents, plans and specifications (where applicable), are issued on bcbid.gov.bc.ca. MERX asks that you refer to bcbid.gov.bc.ca notice for these amendments. MERX stipulates that potential bidders may also be required to register with the buying authority as a bidder/plan taker. The contact information can be found within the notice abstract.